Jardiance for heart failure: How it works, effectiveness & more
The Checkup by Singlecare
MARCH 21, 2024
With reduced EF, empagliflozin was associated with a reduced risk of cardiovascular death and reduced risk of hospitalization for CHF when compared with placebo. Although there is no generic version of Jardiance available currently, there may be as early as 2025. Clinical studies have proven Jardiance’s worth in both types of CHF.
98 
Let's personalize your content